Endosense brings in €25mm through its Series B venture round
Endosense (catheter ablation for cardiac arrhythmias) has raised €25mm ($36mm) through the closing of its Series B venture round. Edmond de Rothschild Investment Partners (EdRIP) led the financing and was joined by NeoMed, GIMV, VI Partners, Sectoral Asset Management, Ysios Capital Partners, and Initiative Capital Romandie. Endosense will use the money for European commercialization (it gained the CE Mark four months ago) and a US PMA study of its TactiCath ablation catheter. Representatives from EdRIP, GIMV, and VI will take seats on the company's board.
- Medical Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com